Asia Pacific Bleeding Disorders Treatment Market By Drug Class (Fibrin Sealant, Desmopressin, Antibrinolytics, Recombinant Coagulation Factor Concentrates And Plasma Derived Coagulation Factor Concentrates), By Type (vWD, Hemophilia A, Hemophilia B) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Asia Pacific Bleeding Disorders Treatment Market By Drug Class (Fibrin Sealant, Desmopressin, Antibrinolytics, Recombinant Coagulation Factor Concentrates And Plasma Derived Coagulation Factor Concentrates), By Type (vWD, Hemophilia A, Hemophilia B) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

ID: 3364 | Pages: 146 | April 2018 | Region: Asia Pacific


The Asia Pacific Bleeding Disorders Treatment Market was worth USD 2.41 billion in 2018 and is estimated to be growing at a CAGR of 8.90%, to reach USD 3.69 billion by 2023. The market is showcasing evident potential in the mentioned forecasting period. A bleeding disorder is a condition which affects the clotting (coagulation) system of the body. If not taken care of this condition properly, serious damage can happen to body in case of any wound or cut due to excessive loss of blood from the body.

There are various types of Bleeding Disorders, but the most frequently seen cases are of Hemophilia A, Hemophilia B and von Willebrand Disease  (vWD). A bleeding Disorder is generally diagnosed by any of these three methods: Platelet Aggregation Test, Complete Blood Count (CBC) and bleeding time. There are various treatment methods depending on the type of bleeding disorder and its severity. Treatments include Iron Supplementation pills, Blood transfusion and other methods.

Because of careless unbalanced diet of teenagers now-a-days in this region, iron deficiency in their body can take place easily, which is the root cause for bleeding disorders. Increasing cases of adulteration of food in this region is one of the reason of many people suffering from bleeding disorders and indirectly supporting this market. Also, the fact that most of the bleeding disorders are inherited and cannot be completely cured is also driving this market. On the other hand, factors such as, high cost of treatment including medication and lack of skilled practitioners to cure these type of disorders are challenging this market.

The Asia-Pacific market for Bleeding Disorders Treatment is broadly categorized by Drug Class and by Disorder Type. On the basis of Drug Class, it is further sub-categorized into Fibrin Sealant, Desmopressin, Antibrinolytics, Recombinant Coagulation Factor Concentrates and Plasma Derived Coagulation Factor Concentrates. On the basis of disorder type, it is sub-categorized into Hemophilia A, Hemophilia B ad vWD. The recombinant coagulation factor concentrates segment is expected to grow the fastest in the mentioned forecast period. This is because of the increased R&D in this market and increasing focus of pharmaceutical companies on recombinant products.

Geographically, Asia-Pacific market is further sub-categorized into India, China, Japan, South Korea and Australia. Asia-Pacific Region has the highest growth rate among all the geographical segments. China leads the market in this region in terms of market share while India has the highest growth rate in this region.

Some of the major companies dominating the market, by their products and services include CSL Behring, Pfizer Inc., Novo Nordisk, Bayer AG, Biogen Inc., Shire Plc., Medline Plus, Janssen Asia-Pacific Services, LLC and Grifos SA.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Drug Class                   

                                5.1.1 Introduction           

                                5.1.2 Fibrin Sealant         

                                5.1.3 Desmopressin       

                                5.1.4 Antibrinolytics       

                                5.1.5 Recombinant Coagulation Factor Concentrates      

                                5.1.6 Plasma Derived Coagulation Factor Concentrates  

                                5.1.7  Y-o-Y Growth Analysis, By Drug Class          

                                5.1.8  Market Attractiveness Analysis, By Drug Class        

                                5.1.9  Market Share Analysis, By Drug Class         

                5.2 Type                              

                                5.2.1 Introduction           

                                5.2.2 vWD           

                                5.2.3 Hemophilia A         

                                5.2.4 Hemophilia B          

                                5.2.5 Y-o-Y Growth Analysis, By Type     

                                5.2.6 Market Attractiveness Analysis, By Type   

                                5.2.7 Market Share Analysis, By Type     

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Drug Class

                                                6.1.3.3 By Type

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Drug Class

                                                6.1.4.3 By Type

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Drug Class

                                                6.1.5.3 By Type

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 CSL Behring                

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Pfizer Inc.                    

                8.3 Novo Nordisk                            

                8.4 Bayer AG                     

                8.5 Biogen Inc.                  

                8.6 Shire Plc.                      

                8.7 LLC                 

                8.8 Medline Plus                              

                8.9 Janssen Global Services                        

                8.10 Grifos SA                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  2. Asia-Pacific Fibrin Sealant Market By Region, From 2018-2023 ( USD Billion )
  3. Asia-Pacific Desmopressin Market By Region, From 2018-2023 ( USD Billion )
  4. Asia-Pacific Antibrinolytics Market By Region, From 2018-2023 ( USD Billion )
  5. Asia-Pacific Recombinant Coagulation Factor Concentrates Market By Region, From 2018-2023 ( USD Billion )
  6. Asia-Pacific Plasma Derived Coagulation Factor Concentrates Market By Region, From 2018-2023 ( USD Billion )
  7. Asia-Pacific Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  8. Asia-Pacific vWD Market By Region, From 2018-2023 ( USD Billion )
  9. Asia-Pacific Hemophilia A Market By Region, From 2018-2023 ( USD Billion )
  10. Asia-Pacific Hemophilia B Market By Region, From 2018-2023 ( USD Billion )
  11. Japan Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  12. Japan Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  13. China Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  14. China Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  15. India Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  16. India Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  17. Australia Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  18. Australia Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  19. South Korea Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  20. South Korea Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
Middle East & Africa Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, ...
Latin America Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Seroton...
Asia Pacific Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Serotoni...
Europe Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Serotonin-nore...
North America Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Seroton...
Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Serotonin-norepinephr...
Middle East and Africa Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables...
Latin America Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrum...
Asia-Pacific Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrume...
Europe Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instruments), ...
North America Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrum...
Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instruments), End Use...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.